Loading...
Header Logo
Keywords
Last Name
Institution

Professor Luc Jean Vanhamme

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Chodzynski KJ, Boudjeltia KZ, Lalmand J, Aminian A, Vanhamme L, de Sousa DR, Gremmo S, Bricteux L, Renotte C, Courbebaisse G, Coussement G. An in vitro test bench reproducing coronary blood flow signals. Biomed Eng Online. 2015 Aug 07; 14:77. PMID: 26250420; PMCID: PMC4527114.
    2. Daher J, Martin M, Rousseau A, Nuyens V, Fayyad-Kazan H, Van Antwerpen P, Courbebaisse G, Martiat P, Badran B, Dequiedt F, Zouaoui Boudjeltia K, Vanhamme L. Myeloperoxidase oxidized LDL interferes with endothelial cell motility through miR-22 and heme oxygenase 1 induction: possible involvement in reendothelialization of vascular injuries. Mediators Inflamm. 2014; 2014:134635. PMID: 25530680; PMCID: PMC4233670.
    3. Kassem A, Pays E, Vanhamme L. Transcription is initiated on silent variant surface glycoprotein expression sites despite monoallelic expression in Trypanosoma brucei. Proc Natl Acad Sci U S A. 2014 Jun 17; 111(24):8943-8. PMID: 24889641; PMCID: PMC4066500.
    4. Nzeusseu Toukap A, Delporte C, Noyon C, Franck T, Rousseau A, Serteyn D, Raes M, Vanhaeverbeek M, Moguilevsky N, Nève J, Vanhamme L, Durez P, Van Antwerpen P, Zouaoui Boudjeltia K. Myeloperoxidase and its products in synovial fluid of patients with treated or untreated rheumatoid arthritis. Free Radic Res. 2014 Apr; 48(4):461-5. PMID: 24460011.
      View in: PubMed
    5. Delporte C, Boudjeltia KZ, Noyon C, Furtmüller PG, Nuyens V, Slomianny MC, Madhoun P, Desmet JM, Raynal P, Dufour D, Koyani CN, Reyé F, Rousseau A, Vanhaeverbeek M, Ducobu J, Michalski JC, Nève J, Vanhamme L, Obinger C, Malle E, Van Antwerpen P. Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100. J Lipid Res. 2014 Apr; 55(4):747-57. PMID: 24534704; PMCID: PMC3966708.
    6. Boudjeltia KZ, Delporte C, Van Antwerpen P, Franck T, Serteyn D, Moguilevsky N, Raes M, Vanhamme L, Vanhaeverbeek M, Van Meerhaeghe A, Roumeguère T. Myeloperoxidase-dependent LDL modifications in bloodstream are mainly predicted by angiotensin II, adiponectin, and myeloperoxidase activity: a cross-sectional study in men. Mediators Inflamm. 2013; 2013:750742. PMID: 24347830; PMCID: PMC3852806.
    7. Dequanter D, Van de Velde M, Nuyens V, Nagy N, Van Antwerpen P, Vanhamme L, Zouaoui Boudjeltia K, Vanhaeverbeek M, Brohée D, Lothaire P. Assessment of oxidative stress in tumors and histologically normal mucosa from patients with head and neck squamous cell carcinoma: a preliminary study. Eur J Cancer Prev. 2013 Nov; 22(6):558-60. PMID: 23492956.
      View in: PubMed
    8. De Muylder G, Daulouède S, Lecordier L, Uzureau P, Morias Y, Van Den Abbeele J, Caljon G, Hérin M, Holzmuller P, Semballa S, Courtois P, Vanhamme L, Stijlemans B, De Baetselier P, Barrett MP, Barlow JL, McKenzie AN, Barron L, Wynn TA, Beschin A, Vincendeau P, Pays E. A Trypanosoma brucei kinesin heavy chain promotes parasite growth by triggering host arginase activity. PLoS Pathog. 2013 Oct; 9(10):e1003731. PMID: 24204274; PMCID: PMC3814429.
    9. Delporte C, Van Antwerpen P, Vanhamme L, Roumeguère T, Zouaoui Boudjeltia K. Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. Mediators Inflamm. 2013; 2013:971579. PMID: 23983406; PMCID: PMC3742028.
    10. Chodzynski KJ, Conotte S, Vanhamme L, Van Antwerpen P, Kerkhofs M, Legros JL, Vanhaeverbeek M, Van Meerhaeghe A, Coussement G, Boudjeltia KZ, Legrand A. A new device to mimic intermittent hypoxia in mice. PLoS One. 2013; 8(4):e59973. PMID: 23565179; PMCID: PMC3615002.
    11. Fayyad-Kazan H, Bitar N, Najar M, Lewalle P, Fayyad-Kazan M, Badran R, Hamade E, Daher A, Hussein N, ElDirani R, Berri F, Vanhamme L, Burny A, Martiat P, Rouas R, Badran B. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Transl Med. 2013 Feb 07; 11:31. PMID: 23391324; PMCID: PMC3579719.
    12. Brasseur A, Rotureau B, Vermeersch M, Blisnick T, Salmon D, Bastin P, Pays E, Vanhamme L, Pérez-Morga D. Trypanosoma brucei FKBP12 differentially controls motility and cytokinesis in procyclic and bloodstream forms. Eukaryot Cell. 2013 Feb; 12(2):168-81. PMID: 23104568; PMCID: PMC3571288.
    13. Delporte C, Franck T, Noyon C, Dufour D, Rousseau A, Madhoun P, Desmet JM, Serteyn D, Raes M, Nortier J, Vanhaeverbeek M, Moguilevsky N, Nève J, Vanhamme L, Van Antwerpen P, Zouaoui Boudjeltia K. Simultaneous measurement of protein-bound 3-chlorotyrosine and homocitrulline by LC-MS/MS after hydrolysis assisted by microwave: application to the study of myeloperoxidase activity during hemodialysis. Talanta. 2012 Sep 15; 99:603-9. PMID: 22967600.
      View in: PubMed
    14. Zouaoui Boudjeltia K, Daher J, Van Antwerpen P, Moguilevsky N, Delree P, Ducobu J, Raes M, Badran B, Vanhaeverbeek M, Brohee D, Remacle C, Vanhamme L. Exposure of endothelial cells to physiological levels of myeloperoxidase-modified LDL delays pericellular fibrinolysis. PLoS One. 2012; 7(6):e38810. PMID: 22723891; PMCID: PMC3378590.
    15. Boudjeltia KZ, Faraut B, Esposito MJ, Stenuit P, Dyzma M, Antwerpen PV, Brohée D, Vanhamme L, Moguilevsky N, Vanhaeverbeek M, Kerkhofs M. Temporal dissociation between myeloperoxidase (MPO)-modified LDL and MPO elevations during chronic sleep restriction and recovery in healthy young men. PLoS One. 2011; 6(11):e28230. PMID: 22140557; PMCID: PMC3227655.
    16. Faraut B, Boudjeltia KZ, Vanhamme L, Kerkhofs M. Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev. 2012 Apr; 16(2):137-49. PMID: 21835655.
      View in: PubMed
    17. Roumeguère T, Delree P, Van Antwerpen P, Rorive S, Vanhamme L, de Ryhove Lde L, Serteyn D, Wespes E, Vanhaerverbeek M, Boudjeltia KZ. Intriguing location of myeloperoxidase in the prostate: a preliminary immunohistochemical study. Prostate. 2012 Apr; 72(5):507-13. PMID: 21739466.
      View in: PubMed
    18. Delporte C, Van Antwerpen P, Zouaoui Boudjeltia K, Noyon C, Abts F, Métral F, Vanhamme L, Reyé F, Rousseau A, Vanhaeverbeek M, Ducobu J, Nève J. Optimization of apolipoprotein-B-100 sequence coverage by liquid chromatography-tandem mass spectrometry for the future study of its posttranslational modifications. Anal Biochem. 2011 Apr 01; 411(1):129-38. PMID: 21129357.
      View in: PubMed
    19. Vanhamme L. The human trypanolytic factor: a drug shaped naturally. Infect Disord Drug Targets. 2010 Aug; 10(4):266-82. PMID: 20429865.
      View in: PubMed
    20. Van Antwerpen P, Slomianny MC, Boudjeltia KZ, Delporte C, Faid V, Calay D, Rousseau A, Moguilevsky N, Raes M, Vanhamme L, Furtmüller PG, Obinger C, Vanhaeverbeek M, Nève J, Michalski JC. Glycosylation pattern of mature dimeric leukocyte and recombinant monomeric myeloperoxidase: glycosylation is required for optimal enzymatic activity. J Biol Chem. 2010 May 21; 285(21):16351-9. PMID: 20332087; PMCID: PMC2871502.
    21. Decrem Y, Rath G, Blasioli V, Cauchie P, Robert S, Beaufays J, Frère JM, Feron O, Dogné JM, Dessy C, Vanhamme L, Godfroid E. Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis. J Exp Med. 2009 Oct 26; 206(11):2381-95. PMID: 19808248; PMCID: PMC2768864.
    22. Prevot PP, Beschin A, Lins L, Beaufays J, Grosjean A, Bruys L, Adam B, Brossard M, Brasseur R, Zouaoui Boudjeltia K, Vanhamme L, Godfroid E. Exosites mediate the anti-inflammatory effects of a multifunctional serpin from the saliva of the tick Ixodes ricinus. FEBS J. 2009 Jun; 276(12):3235-46. PMID: 19438720.
      View in: PubMed
    23. Beaufays J, Adam B, Menten-Dedoyart C, Fievez L, Grosjean A, Decrem Y, Prévôt PP, Santini S, Brasseur R, Brossard M, Vanhaeverbeek M, Bureau F, Heinen E, Lins L, Vanhamme L, Godfroid E. Ir-LBP, an ixodes ricinus tick salivary LTB4-binding lipocalin, interferes with host neutrophil function. PLoS One. 2008; 3(12):e3987. PMID: 19096526; PMCID: PMC2600610.
    24. Beaufays J, Adam B, Decrem Y, Prévôt PP, Santini S, Brasseur R, Brossard M, Lins L, Vanhamme L, Godfroid E. Ixodes ricinus tick lipocalins: identification, cloning, phylogenetic analysis and biochemical characterization. PLoS One. 2008; 3(12):e3941. PMID: 19096708; PMCID: PMC2601031.
    25. Vanhamme L. Trypanosome RNA polymerases and transcription factors: sensible trypanocidal drug targets? Curr Drug Targets. 2008 Nov; 9(11):979-96. PMID: 18991610.
      View in: PubMed
    26. Uzureau P, Daniels JP, Walgraffe D, Wickstead B, Pays E, Gull K, Vanhamme L. Identification and characterization of two trypanosome TFIIS proteins exhibiting particular domain architectures and differential nuclear localizations. Mol Microbiol. 2008 Sep; 69(5):1121-36. PMID: 18627464; PMCID: PMC2610381.
    27. Decrem Y, Beaufays J, Blasioli V, Lahaye K, Brossard M, Vanhamme L, Godfroid E. A family of putative metalloproteases in the salivary glands of the tick Ixodes ricinus. FEBS J. 2008 Apr; 275(7):1485-99. PMID: 18279375.
      View in: PubMed
    28. Adam B, Charloteaux B, Beaufays J, Vanhamme L, Godfroid E, Brasseur R, Lins L. Distantly related lipocalins share two conserved clusters of hydrophobic residues: use in homology modeling. BMC Struct Biol. 2008 Jan 11; 8:1. PMID: 18190694; PMCID: PMC2254393.
    29. Couvreur B, Beaufays J, Charon C, Lahaye K, Gensale F, Denis V, Charloteaux B, Decrem Y, Prévôt PP, Brossard M, Vanhamme L, Godfroid E. Variability and action mechanism of a family of anticomplement proteins in Ixodes ricinus. PLoS One. 2008 Jan 02; 3(1):e1400. PMID: 18167559; PMCID: PMC2151134.
    30. Decrem Y, Mariller M, Lahaye K, Blasioli V, Beaufays J, Zouaoui Boudjeltia K, Vanhaeverbeek M, Cérutti M, Brossard M, Vanhamme L, Godfroid E. The impact of gene knock-down and vaccination against salivary metalloproteases on blood feeding and egg laying by Ixodes ricinus. Int J Parasitol. 2008 Apr; 38(5):549-60. PMID: 17959179.
      View in: PubMed
    31. Lecordier L, Devaux S, Uzureau P, Dierick JF, Walgraffe D, Poelvoorde P, Pays E, Vanhamme L. Characterization of a TFIIH homologue from Trypanosoma brucei. Mol Microbiol. 2007 Jun; 64(5):1164-81. PMID: 17542913.
      View in: PubMed
    32. Uzureau P, Felu C, De Muylder G, Pays E, Vanhamme L. G418, phleomycin and hygromycin selection of recombinant Trypanosoma brucei parasites refractory to long-term in vitro culture. Mol Biochem Parasitol. 2007 Jul; 154(1):90-4. PMID: 17449118.
      View in: PubMed
    33. Vanhollebeke B, Nielsen MJ, Watanabe Y, Truc P, Vanhamme L, Nakajima K, Moestrup SK, Pays E. Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum. Proc Natl Acad Sci U S A. 2007 Mar 06; 104(10):4118-23. PMID: 17360487; PMCID: PMC1820718.
    34. Devaux S, Kelly S, Lecordier L, Wickstead B, Perez-Morga D, Pays E, Vanhamme L, Gull K. Diversification of function by different isoforms of conventionally shared RNA polymerase subunits. Mol Biol Cell. 2007 Apr; 18(4):1293-301. PMID: 17267688; PMCID: PMC1838988.
    35. Prevot PP, Couvreur B, Denis V, Brossard M, Vanhamme L, Godfroid E. Protective immunity against Ixodes ricinus induced by a salivary serpin. Vaccine. 2007 Apr 30; 25(17):3284-92. PMID: 17270322.
      View in: PubMed
    36. Pays E, Vanhollebeke B, Vanhamme L, Paturiaux-Hanocq F, Nolan DP, Pérez-Morga D. The trypanolytic factor of human serum. Nat Rev Microbiol. 2006 Jun; 4(6):477-86. PMID: 16710327.
      View in: PubMed
    37. Prevot PP, Adam B, Boudjeltia KZ, Brossard M, Lins L, Cauchie P, Brasseur R, Vanhaeverbeek M, Vanhamme L, Godfroid E. Anti-hemostatic effects of a serpin from the saliva of the tick Ixodes ricinus. J Biol Chem. 2006 Sep 08; 281(36):26361-9. PMID: 16672226.
      View in: PubMed
    38. Devaux S, Lecordier L, Uzureau P, Walgraffe D, Dierick JF, Poelvoorde P, Pays E, Vanhamme L. Characterization of RNA polymerase II subunits of Trypanosoma brucei. Mol Biochem Parasitol. 2006 Jul; 148(1):60-8. PMID: 16621069.
      View in: PubMed
    39. Pérez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F, Nolan DP, Lins L, Homblé F, Vanhamme L, Tebabi P, Pays A, Poelvoorde P, Jacquet A, Brasseur R, Pays E. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science. 2005 Jul 15; 309(5733):469-72. PMID: 16020735.
      View in: PubMed
    40. Lecordier L, Walgraffe D, Devaux S, Poelvoorde P, Pays E, Vanhamme L. Trypanosoma brucei RNA interference in the mammalian host. Mol Biochem Parasitol. 2005 Mar; 140(1):127-31. PMID: 15694495.
      View in: PubMed
    41. Walgraffe D, Devaux S, Lecordier L, Dierick JF, Dieu M, Van den Abbeele J, Pays E, Vanhamme L. Characterization of subunits of the RNA polymerase I complex in Trypanosoma brucei. Mol Biochem Parasitol. 2005 Feb; 139(2):249-60. PMID: 15664659.
      View in: PubMed
    42. Salmon D, Paturiaux-Hanocq F, Poelvoorde P, Vanhamme L, Pays E. Trypanosoma brucei: growth differences in different mammalian sera are not due to the species-specificity of transferrin. Exp Parasitol. 2005 Mar; 109(3):188-94. PMID: 15713451.
      View in: PubMed
    43. Pays E, Vanhamme L, Pérez-Morga D. Antigenic variation in Trypanosoma brucei: facts, challenges and mysteries. Curr Opin Microbiol. 2004 Aug; 7(4):369-74. PMID: 15288623.
      View in: PubMed
    44. Vanhamme L, Pays E. The trypanosome lytic factor of human serum and the molecular basis of sleeping sickness. Int J Parasitol. 2004 Jul; 34(8):887-98. PMID: 15217727.
      View in: PubMed
    45. Vanhamme L, Renauld H, Lecordier L, Poelvoorde P, Van Den Abbeele J, Pays E. The Trypanosoma brucei reference strain TREU927/4 contains T. brucei rhodesiense-specific SRA sequences, but displays a distinct phenotype of relative resistance to human serum. Mol Biochem Parasitol. 2004 May; 135(1):39-47. PMID: 15287585.
      View in: PubMed
    46. Poelvoorde P, Vanhamme L, Van Den Abbeele J, Switzer WM, Pays E. Distribution of apolipoprotein L-I and trypanosome lytic activity among primate sera. Mol Biochem Parasitol. 2004 Mar; 134(1):155-7. PMID: 14747153.
      View in: PubMed
    47. Amiguet-Vercher A, Pérez-Morga D, Pays A, Poelvoorde P, Van Xong H, Tebabi P, Vanhamme L, Pays E. Loss of the mono-allelic control of the VSG expression sites during the development of Trypanosoma brucei in the bloodstream. Mol Microbiol. 2004 Mar; 51(6):1577-88. PMID: 15009886.
      View in: PubMed
    48. Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan DP, Lins L, Van Den Abbeele J, Pays A, Tebabi P, Van Xong H, Jacquet A, Moguilevsky N, Dieu M, Kane JP, De Baetselier P, Brasseur R, Pays E. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature. 2003 Mar 06; 422(6927):83-7. PMID: 12621437.
      View in: PubMed
    49. Radwanska M, Chamekh M, Vanhamme L, Claes F, Magez S, Magnus E, de Baetselier P, Büscher P, Pays E. The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense. Am J Trop Med Hyg. 2002 Dec; 67(6):684-90. PMID: 12518862.
      View in: PubMed
    50. Vanhamme L, Pays E, McCulloch R, Barry JD. An update on antigenic variation in African trypanosomes. Trends Parasitol. 2001 Jul; 17(7):338-43. PMID: 11423377.
      View in: PubMed
    51. Vanhamme L, Lecordier L, Pays E. Control and function of the bloodstream variant surface glycoprotein expression sites in Trypanosoma brucei. Int J Parasitol. 2001 May 01; 31(5-6):523-31. PMID: 11334937.
      View in: PubMed
    52. Pays E, Lips S, Nolan D, Vanhamme L, Pérez-Morga D. The VSG expression sites of Trypanosoma brucei: multipurpose tools for the adaptation of the parasite to mammalian hosts. Mol Biochem Parasitol. 2001 Apr 25; 114(1):1-16. PMID: 11356509.
      View in: PubMed
    53. Radwanska M, Couvreur B, Dumont N, Pays A, Vanhamme L, Pays E. A transcript encoding a proteasome beta-subunit and a zinc finger protein in Trypanosoma brucei brucei. Gene. 2000 Sep 05; 255(1):43-50. PMID: 10974563.
      View in: PubMed
    54. Paturiaux-Hanocq F, Hanocq-Quertier J, de Almeida ML, Nolan DP, Pays A, Vanhamme L, Van den Abbeele J, Wasunna CL, Carrington M, Pays E. A role for the dynamic acylation of a cluster of cysteine residues in regulating the activity of the glycosylphosphatidylinositol-specific phospholipase C of Trypanosoma brucei. J Biol Chem. 2000 Apr 21; 275(16):12147-55. PMID: 10766850.
      View in: PubMed
    55. Vanhamme L, Poelvoorde P, Pays A, Tebabi P, Van Xong H, Pays E. Differential RNA elongation controls the variant surface glycoprotein gene expression sites of Trypanosoma brucei. Mol Microbiol. 2000 Apr; 36(2):328-40. PMID: 10792720.
      View in: PubMed
    56. Berberof M, Vanhamme L, Alexandre S, Lips S, Tebabi P, Pays E. A single-stranded DNA-binding protein shared by telomeric repeats, the variant surface glycoprotein transcription promoter and the procyclin transcription terminator of Trypanosoma brucei. Nucleic Acids Res. 2000 Jan 15; 28(2):597-604. PMID: 10606660; PMCID: PMC102509.
    57. Vanhamme L, Postiaux S, Poelvoorde P, Pays E. Differential regulation of ESAG transcripts in Trypanosoma brucei. Mol Biochem Parasitol. 1999 Jul 30; 102(1):35-42. PMID: 10477174.
      View in: PubMed
    58. Xong HV, Vanhamme L, Chamekh M, Chimfwembe CE, Van Den Abbeele J, Pays A, Van Meirvenne N, Hamers R, De Baetselier P, Pays E. A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell. 1998 Dec 11; 95(6):839-46. PMID: 9865701.
      View in: PubMed
    59. Clayton C, Adams M, Almeida R, Baltz T, Barrett M, Bastien P, Belli S, Beverley S, Biteau N, Blackwell J, Blaineau C, Boshart M, Bringaud F, Cross G, Cruz A, Degrave W, Donelson J, El-Sayed N, Fu G, Ersfeld K, Gibson W, Gull K, Ivens A, Kelly J, Vanhamme L, et al. Genetic nomenclature for Trypanosoma and Leishmania. Mol Biochem Parasitol. 1998 Nov 30; 97(1-2):221-4. PMID: 9879900.
      View in: PubMed
    60. Vanhamme L, Perez-Morga D, Marchal C, Speijer D, Lambert L, Geuskens M, Alexandre S, Ismaïli N, Göringer U, Benne R, Pays E. Trypanosoma brucei TBRGG1, a mitochondrial oligo(U)-binding protein that co-localizes with an in vitro RNA editing activity. J Biol Chem. 1998 Aug 21; 273(34):21825-33. PMID: 9705321.
      View in: PubMed
    61. Vanhamme L, Pays E. Controls of the expression of the Vsg in Trypanosoma brucei. Mol Biochem Parasitol. 1998 Mar 01; 91(1):107-16. PMID: 9574929.
      View in: PubMed
    62. Webb H, Carnall N, Vanhamme L, Rolin S, Van Den Abbeele J, Welburn S, Pays E, Carrington M. The GPI-phospholipase C of Trypanosoma brucei is nonessential but influences parasitemia in mice. J Cell Biol. 1997 Oct 06; 139(1):103-14. PMID: 9314532; PMCID: PMC2139819.
    63. Paturiaux-Hanocq F, Zitzmann N, Hanocq-Quertier J, Vanhamme L, Rolin S, Geuskens M, Ferguson MA, Pays E. Expression of a variant surface glycoprotein of Trypanosoma gambiense in procyclic forms of Trypanosoma brucei shows that the cell type dictates the nature of the glycosylphosphatidylinositol membrane anchor attached to the glycoprotein. Biochem J. 1997 Jun 15; 324 ( Pt 3):885-95. PMID: 9210413; PMCID: PMC1218505.
    64. Vanhamme L, Pays A, Tebabi P, Alexandre S, Pays E. Specific binding of proteins to the noncoding strand of a crucial element of the variant surface glycoprotein, procyclin, and ribosomal promoters of trypanosoma brucei. Mol Cell Biol. 1995 Oct; 15(10):5598-606. PMID: 7565711; PMCID: PMC230810.
    65. Berberof M, Vanhamme L, Tebabi P, Pays A, Jefferies D, Welburn S, Pays E. The 3'-terminal region of the mRNAs for VSG and procyclin can confer stage specificity to gene expression in Trypanosoma brucei. EMBO J. 1995 Jun 15; 14(12):2925-34. PMID: 7796818; PMCID: PMC398412.
    66. Vanhamme L, Berberof M, Le Ray D, Pays E. Stimuli of differentiation regulate RNA elongation in the transcription units for the major stage-specific antigens of Trypanosoma brucei. Nucleic Acids Res. 1995 Jun 11; 23(11):1862-9. PMID: 7596810; PMCID: PMC306955.
    67. Vanhamme L, Pays E. Control of gene expression in trypanosomes. Microbiol Rev. 1995 Jun; 59(2):223-40. PMID: 7603410; PMCID: PMC239361.
    68. Berberof M, Vanhamme L, Pays E. Trypanosoma brucei: a preferential splicing at the inverted polyadenylation site of the VSG mRNA provides further evidence for coupling between trans-splicing and polyadenylation. Exp Parasitol. 1995 May; 80(3):563-7. PMID: 7729491.
      View in: PubMed
    69. Berghman LR, Grauwels L, Vanhamme L, Vandesande F. A simple method for the immunocytochemical processing of large numbers of floating sections and its application in screening for monoclonal antibodies. J Immunol Methods. 1994 Feb 10; 168(2):197-202. PMID: 8308294.
      View in: PubMed
    70. Pays E, Vanhamme L, Berberof M. Genetic controls for the expression of surface antigens in African trypanosomes. Annu Rev Microbiol. 1994; 48:25-52. PMID: 7826007.
      View in: PubMed
    71. Vanhamme L, Szpirer C. Spontaneous and 5-azacytidine-induced revertants of methionine-dependent tumor-derived and H-ras-1-transformed cells. Exp Cell Res. 1989 Mar; 181(1):159-68. PMID: 2465163.
      View in: PubMed
    72. Vanhamme L, Rolin S, Szpirer C. Inhibition of gap-junctional intercellular communication between epithelial cells transformed by the activated H-ras-1 oncogene. Exp Cell Res. 1989 Jan; 180(1):297-301. PMID: 2535816.
      View in: PubMed
    73. Vanhamme L, Szpirer C. Transforming activity of the human mammary line HBL100 DNA is associated with SV40 large T antigen genetic information integrated in its genome. Carcinogenesis. 1988 Apr; 9(4):653-5. PMID: 3281770.
      View in: PubMed
    Vanhamme's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description